Prognostic factors in small cell lung cancer: A new prognostic index in Korean patients

Oncology

Volumn 79, Issue 3-4, 2011, Pages 293-300

  Hong, Soojung ^a,b   Cho, Byoung Chul ^b   Choi, Hye Jin ^b   Jung, Minkyu ^b   Lee, Soo Hyeon ^b   Park, Kyung Soo ^b   Kim, Se Kyu ^b   Kim, Joo Hang ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

CYFRA 21 1; Disease extent; Performance status; Prognostic factors; Small cell lung cancer; Survival

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; CISPLATIN; CYTOKERATIN 19 FRAGMENT; ETOPOSIDE; IFOSFAMIDE; IRINOTECAN; LACTATE DEHYDROGENASE; SODIUM;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; FEMALE; FOLLOW UP; HUMAN; KOREA; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER METASTASIS; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PARANEOPLASTIC SYNDROME; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SUPERIOR CAVA VEIN SYNDROME; SURVIVAL TIME; THROMBOCYTE COUNT; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATIN-19; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; SURVIVORS;

EID: 79952610948     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323333     Document Type: Article

References (41)

1. Buccheri G, Ferrigno D: Prognostic factors of small cell lung cancer. Hematol Oncol Clin North Am 2004; 18: 445-460. (Pubitemid 38496477)
2. Micke P, Faldum A, Metz T, Beeh KM, Bit-tinger F, Hengstler JG, Buhl R: Staging small cell lung cancer: Veterans Administration Lung Study Group versus International As-sociation for the Study of Lung Cancer-what limits limited disease? Lung Cancer 2002; 37: 271-276. (Pubitemid 35286725)
3. Bremnes RM, Sundstrom S, Aasebø U, Kaasa S, Hatlevoll R, Aamdal S: The value of prog-nostic factors in small cell lung cancer: re-sults from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer 2003; 39: 303-313. (Pubitemid 36279450)
4. Sagman U, Maki E, Evans WK, Warr D, Shepherd FA, Sculier JP, Haddad R, Payne D, Pringle JF, Yeoh JL: Small-cell carcinoma of the lung: derivation of a prognostic staging system. J Clin Oncol 1991; 9: 1639-1649.
5. Seifter EJ, Ihde DC: Therapy of small cell lung cancer: a perspective on two decades of clini-cal research. Semin Oncol 1988; 15:278-299.
6. Evans WK, Shepherd FA, Feld R, Osoba D, Dang P, Deboer G: VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol 1985; 3:1471-1477. (Pubitemid 16246758)
7. Murray N, Coy P, Pater JL, Hodson I, Arnold A, Zee BC, Payne D, Kostashuk EC, Evans WK, Dixon P: Importance of timing for tho-racic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993; 11:336-344. (Pubitemid 23046826)
8. Arriagada R, Le Chevalier T, Borie F, Rivière A, Chomy P, Monnet I, Tardivon A, Viader F, Tarayre M, Benhamou S: Prophylactic cra-nial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Instit 1995; 87: 183-190.
9. Aupérin A, Arriagada R, Pignon JP, Le Péchoux C, Gregor A, Stephens RJ, Kristjan-sen PE, Johnson BE, Ueoka H, Wagner H, Aisner J: Prophylactic cranial irradiation for patients with small-cell lung cancer in com-plete remission. Prophylactic Cranial Irra-diation Overview Collaborative Group. N Engl J Med 1999; 341: 476-484. (Pubitemid 29372887)
10. Spiegelman D, Maurer LH, Ware JH, Perry MC, Chahinian AP, Comis R Eaton W, Zimmer B, Green M: Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients. J Clin Oncol 1989; 7:344-354. (Pubitemid 19075016)
11. Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J: Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecu-tive prospective trials with a minimum fol-low-up of 5 years. Cancer 2000; 89:523-533. (Pubitemid 30640099)
12. Stanley KE: Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980; 65:25-32. (Pubitemid 10071592)
13. Osterlind K, Andersen PK: Prognostic fac-tors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation. Cancer Res 1986; 46:4189-4194. (Pubitemid 16075929)
14. Gronowitz JS, Bergstrom R, Nou E, Pahlman S, Brodin O, Nilsson S, Kallander CF: Clini-cal and serologic markers of stage and prog-nosis in small cell lung cancer. A multivari-ate analysis. Cancer 1990; 66:722-732. (Pubitemid 20281316)
15. Albain KS, Crowley JJ, LeBlanc M, Livings-ton RB: Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990; 8:1563-1574. (Pubitemid 20301188)
16. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, Vincent MD, Yu EW: Continued cigarette smoking by patients re-ceiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is asso-ciated with decreased survival. J Clin Oncol 2003; 21:1544-1549. (Pubitemid 46594108)
17. Allan SG, Stewart ME, Love S, Cornbleet MA, Smyth JF, Leonard RC: Prognosis at presentation of small cell carcinoma of the lung. Eur J Cancer 1990; 26: 703-705. (Pubitemid 20275104)
18. Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N: Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer 1987; 39:146-149. (Pubitemid 17015271)
19. Cohen MH, Makuch R, Johnston-Early A, Ihde DC, Bunn PA Jr, Fossieck BE Jr, Minna JD: Laboratory parameters as an alternative to performance status in prognostic stratifi-cation of patients with small cell lung cancer. Cancer Treat Rep 1981; 65: 187-195. (Pubitemid 11071424)
20. Jorgensen LG, Osterlind K, Genolla J, Gomm SA, Hernandez JR, Johnson PW, Lober J, Splinter TA, Szturmowicz M: Serum neu-ron-specific enolase (S-NSE) and the prog-nosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres. Br J Cancer 1996; 74:463-467. (Pubitemid 26254580)
21. Kawahara M, Fukuoka M, Saijo N, Nishiwa-ki Y, Ikegami H, Tamura T, Shimoyama M, Suemasu K, Furuse K: Prognostic factors and prognostic staging system for small cell lung cancer. Jpn J Clin Oncol 1997; 27:158-165. (Pubitemid 127516324)
22. Laberge F, Fritsche HA, Umsawasdi T, Carr DT, Welch S, Murphy WK, Chiuten DF, Dhingra HM, Farha P, Spitzer G, et al: Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1. Cancer 1987; 59: 2047-2052. (Pubitemid 17077788)
23. Maestu I, Pastor M, Gomez-Codina J, Apari-cio J, Oltra A, Herranz C, Montalar J, Mu-narriz B, Reynes G: Pretreatment prognostic factors for survival in small-cell lung cancer: a new prognostic index and validation of three known prognostic indices on 341 pa-tients. Ann Oncol 1997; 8:547-553.
24. Pujol JL, Quantin X, Jacot W, Boher JM, Gre-nier J, Lamy PJ: Neuroendocrine and cyto-keratin serum markers as prognostic deter-minants of small cell lung cancer. Lung Cancer 2003; 39: 131-138. (Pubitemid 36173612)
25. Rawson NS, Peto J: An overview of prognos-tic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Co-ordinating Committee on Cancer Research. Br J Cancer 1990; 61: 597-604. (Pubitemid 20126342)
26. Sculier JP, Feld R, Evans WK, Shepherd FA, DeBoer G, Malkin DG, Malkin A: Carcino-embryonic antigen: a useful prognostic marker in small-cell lung cancer. J Clin On-col 1985; 3:1349-1354. (Pubitemid 15244931)
27. Souhami RL, Earl HM, Ash CM, Spiro SG, Geddes D, Harper PG, Tobias JS: Prognostic factors in patients with small-cell lung Cancer: preliminary results from a large ran-domised study. Antibiot Chemother 1988; 41: 77-82.
28. Toh CK, Hee SW, Lim WT, Leong SS, Fong KW, Yap SP, Hsu AA, Eng P, Koong HN, Agasthian T, Tan EH: Survival of small-cell lung cancer and its determinants of outcome in Singapore. Ann Acad Med Singapore 2007; 36: 181-188. (Pubitemid 46877760)
29. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al: New guidelines to evaluate the response to treatment in solid tumors. European Orga-nization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
30. Christodolou C, Pavlidis N, Samantas E, Fountzilas G, Kouvatseas G, Pagdatoglou K Palamidas F, Nikolaidis C, Angelidou M, Kalofonos HP, Kosmidis P, Skarlos DV: Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group study. Anti-cancer Res 2002; 22: 3749-3757. (Pubitemid 36132861)
31. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W: Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Ann Behav Med 2003; 26: 172-181. (Pubitemid 38001837)
32. Tamura M, Ueoka H, Kiura K, Tabata M, Shibayama T, Miyatake K, Gemba K, Hiraki S, Harada M: Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials. Acta Med Okayama 1998; 52: 105-111. (Pubitemid 128456895)
33. Yip D, Harper PG: Predictive and prognostic factors in small cell lung cancer: current sta-tus. Lung Cancer 2000; 28:173-185. (Pubitemid 30254226)
34. Song LH, Song XR, Zhang XQ, Qi JL, Li XJ, Tian H, Bu B: Prognostic factors in patients with small cell lung cancer (in Chinese). Zhonghua Zhong Liu Za Zhi 2004; 26: 413-416.
35. Wolf T, Gillenwater HH: Treatment options for small cell lung cancer. Curr Oncol Rep 2004; 6:268-271. (Pubitemid 39359496)
36. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE, Ihde DC, Bunn PA, Matthews MJ, Makuch R: Smoking absti-nence and small cell lung cancer survival. An association. JAMA 1980; 244:2175-2179. (Pubitemid 10025379)
37. Bergman B, Sorenson S: Smoking and effect of chemotherapy in small cell lung cancer. Eur Respir J 1988; 1: 932-937. (Pubitemid 19015307)
38. de Wet M, Falkson G, Rapoport BL: Small cell lung cancer: analysis of factors influenc-ing the response to treatment and survival. Oncology 1994; 51: 523-534. (Pubitemid 24347036)
39. Molina R, Agusti C, Mañe JM, Filella X, Jo J, Joseph J, Giménez N, Estapé J, Ballesta AM: CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum lev-els. Int J Biol Markers 1994; 9: 96-101. (Pubitemid 24225520)
40. Kinoshita M, Watanabe H, Ichiki M, Sumita S, Okubo Y, Matsunami M, Furuno H, Shi-raishi T, Rikimaru T, Oizumi K: CYFRA 21-1 as a marker of lung cancer. Kurume Med J 1998; 45: 7-9. (Pubitemid 128515046)
41. Lassen U, Osterlind K, Hansen M, Domber-nowsky P, Bergman B, Hansen HH: Long-term survival in small-cell lung cancer: post-treatment characteristics in patients surviv-ing 5 to 18+ years-an analysis of 1,714 consecutive patients. J Clin Oncol 1995; 13: 1215-1220.